MGNX
Price
$4.21
Change
+$0.16 (+3.95%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
257.43M
69 days until earnings call
Intraday BUY SELL Signals
TENX
Price
$10.78
Change
-$0.17 (-1.55%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
317.51M
Intraday BUY SELL Signals
Interact to see
Advertisement

MGNX vs TENX

Header iconMGNX vs TENX Comparison
Open Charts MGNX vs TENXBanner chart's image
MGNX vs TENX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MGNX vs. TENX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2026
Stock price -- (MGNX: $4.05 vs. TENX: $10.95)
Brand notoriety: MGNX and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 46% vs. TENX: 146%
Market capitalization -- MGNX: $257.43M vs. TENX: $317.51M
MGNX [@Biotechnology] is valued at $257.43M. TENX’s [@Biotechnology] market capitalization is $317.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 0 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 0 green, 5 red.
According to our system of comparison, TENX is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 3 TA indicator(s) are bullish while TENX’s TA Score has 3 bullish TA indicator(s).

  • MGNX’s TA Score: 3 bullish, 6 bearish.
  • TENX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both MGNX and TENX are a bad buy in the short-term.

Price Growth

MGNX (@Biotechnology) experienced а -9.40% price change this week, while TENX (@Biotechnology) price change was -8.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

MGNX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TENX($318M) has a higher market cap than MGNX($257M). MGNX YTD gains are higher at: 151.553 vs. TENX (-10.172). TENX has higher annual earnings (EBITDA): -43.33M vs. MGNX (-63.11M). MGNX has more cash in the bank: 146M vs. TENX (99.4M). TENX has less debt than MGNX: TENX (279K) vs MGNX (37M). MGNX has higher revenues than TENX: MGNX (126M) vs TENX (0).
MGNXTENXMGNX / TENX
Capitalization257M318M81%
EBITDA-63.11M-43.33M146%
Gain YTD151.553-10.172-1,490%
P/E RatioN/A2.41-
Revenue126M0-
Total Cash146M99.4M147%
Total Debt37M279K13,262%
FUNDAMENTALS RATINGS
MGNX vs TENX: Fundamental Ratings
MGNX
TENX
OUTLOOK RATING
1..100
9189
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3543
P/E GROWTH RATING
1..100
9482
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (43) in the Medical Specialties industry is somewhat better than the same rating for MGNX (91) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than MGNX’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MGNX (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to MGNX’s over the last 12 months.

TENX's SMR Rating (99) in the Medical Specialties industry is in the same range as MGNX (99) in the Biotechnology industry. This means that TENX’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's Price Growth Rating (35) in the Biotechnology industry is in the same range as TENX (43) in the Medical Specialties industry. This means that MGNX’s stock grew similarly to TENX’s over the last 12 months.

TENX's P/E Growth Rating (82) in the Medical Specialties industry is in the same range as MGNX (94) in the Biotechnology industry. This means that TENX’s stock grew similarly to MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXTENX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
84%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signal:
Gain/Loss:
TENX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FKEMX62.97N/A
N/A
Fidelity Emerging Markets K
PGRTX18.18N/A
N/A
Principal SmallCap Growth I Instl
PJERX17.81N/A
N/A
PGIM Jennison Global Equity Income R
MVGAX17.79N/A
N/A
MFS Low Volatility Global Equity A
PGKRX37.81N/A
N/A
PGIM Jennison Technology R6

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with KRRO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
-2.17%
KRRO - MGNX
45%
Loosely correlated
-14.93%
AMRN - MGNX
44%
Loosely correlated
+1.25%
VYGR - MGNX
41%
Loosely correlated
-5.15%
MGX - MGNX
35%
Loosely correlated
+1.53%
CELC - MGNX
35%
Loosely correlated
-25.66%
More

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
-8.52%
AVXL - TENX
47%
Loosely correlated
-6.71%
CORT - TENX
41%
Loosely correlated
+1.08%
ANAB - TENX
30%
Poorly correlated
-3.61%
GANX - TENX
29%
Poorly correlated
-6.89%
MGNX - TENX
29%
Poorly correlated
-2.17%
More